IBB
IBB
iShares Biotechnology ETF • IShares
$174.68 ▼ -0.75% (-1.31)
Managing Company IShares
Asset Under Management $8.49B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $116.25
Volume 447,579.004
Avg Volume 1,757,520
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Managing Company IShares
Asset Under Management $8.49B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $116.25
Volume 447,579.004
Avg Volume 1,757,520
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 7.50% | 4.53M | $636.21M |
 AMGN | Amgen Inc. | 7.19% | 1.74M | $610.15M |
 VRTX | Vertex Pharmaceuticals Incorporated | 7.11% | 1.36M | $603.45M |
 REGN | Regeneron Pharmaceuticals, Inc. | 6.77% | 760.60K | $574.64M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.93% | 982.70K | $333.54M |
 ARGX | argenx SE | 3.34% | 342.63K | $283.82M |
 INSM | Insmed Incorporated | 2.88% | 1.59M | $244.34M |
 NTRA | Natera, Inc. | 2.49% | 983.68K | $211.14M |
 BIIB | Biogen Inc. | 2.31% | 1.09M | $195.86M |
 RVMD | Revolution Medicines, Inc. | 2.23% | 1.29M | $189.21M |
 UTHR | United Therapeutics Corporation | 2.16% | 316.49K | $183.10M |
 ONC | BeOne Medicines Ltd. | 1.94% | 530.79K | $164.55M |
 ILMN | Illumina, Inc. | 1.71% | 1.11M | $144.75M |
 INCY | Incyte Corporation | 1.70% | 1.47M | $143.85M |
 MRNA | Moderna, Inc. | 1.68% | 2.70M | $142.63M |
 ROIV | Roivant Sciences Ltd. | 1.25% | 3.65M | $106.31M |
 GMAB | Genmab A/S | 1.22% | 3.57M | $103.63M |
 BBIO | BridgeBio Pharma, Inc. | 1.14% | 1.24M | $96.83M |
 NBIX | Neurocrine Biosciences, Inc. | 1.13% | 729.77K | $95.46M |
 IONS | Ionis Pharmaceuticals, Inc. | 1.09% | 1.21M | $92.83M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Denmark
United Kingdom
Canada
Germany
Ireland
France
Switzerland
China
Singapore
Jersey
Belgium
Spain
Australia
Cayman Islands Other
0.06%
Italy
Iceland.svg)
Taiwan (Province of China)SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Denmark United Kingdom Canada Germany Ireland France Switzerland China Singapore Jersey Belgium Spain Australia Cayman Islands Other
0.06% Italy Iceland Taiwan (Province of China)Holdings (Top 20)
GILD
Gilead Sciences, Inc.
Weight: 7.50% Shares: 4.53M Value: $636.21M
AMGN
Amgen Inc.
Weight: 7.19% Shares: 1.74M Value: $610.15M
VRTX
Vertex Pharmaceuticals Incorporated
Weight: 7.11% Shares: 1.36M Value: $603.45M
REGN
Regeneron Pharmaceuticals, Inc.
Weight: 6.77% Shares: 760.60K Value: $574.64M
ALNY
Alnylam Pharmaceuticals, Inc.
Weight: 3.93% Shares: 982.70K Value: $333.54M
ARGX
argenx SE
Weight: 3.34% Shares: 342.63K Value: $283.82M
INSM
Insmed Incorporated
Weight: 2.88% Shares: 1.59M Value: $244.34M
NTRA
Natera, Inc.
Weight: 2.49% Shares: 983.68K Value: $211.14M
BIIB
Biogen Inc.
Weight: 2.31% Shares: 1.09M Value: $195.86M
RVMD
Revolution Medicines, Inc.
Weight: 2.23% Shares: 1.29M Value: $189.21M
UTHR
United Therapeutics Corporation
Weight: 2.16% Shares: 316.49K Value: $183.10M
ONC
BeOne Medicines Ltd.
Weight: 1.94% Shares: 530.79K Value: $164.55M
ILMN
Illumina, Inc.
Weight: 1.71% Shares: 1.11M Value: $144.75M
INCY
Incyte Corporation
Weight: 1.70% Shares: 1.47M Value: $143.85M
MRNA
Moderna, Inc.
Weight: 1.68% Shares: 2.70M Value: $142.63M
ROIV
Roivant Sciences Ltd.
Weight: 1.25% Shares: 3.65M Value: $106.31M
GMAB
Genmab A/S
Weight: 1.22% Shares: 3.57M Value: $103.63M
BBIO
BridgeBio Pharma, Inc.
Weight: 1.14% Shares: 1.24M Value: $96.83M
NBIX
Neurocrine Biosciences, Inc.
Weight: 1.13% Shares: 729.77K Value: $95.46M
IONS
Ionis Pharmaceuticals, Inc.
Weight: 1.09% Shares: 1.21M Value: $92.83M